Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Equity Ratio (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Equity Ratio readings, the most recent being 0.18 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 35.23% to 0.18 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.18, a 35.23% decrease, with the full-year FY2025 number at 0.18, down 35.23% from a year prior.
  • Equity Ratio hit 0.18 in Q4 2025 for Tandem Diabetes Care, up from 0.15 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.48 in Q4 2021 to a low of 0.15 in Q3 2025.
  • Median Equity Ratio over the past 5 years was 0.34 (2023), compared with a mean of 0.33.
  • Biggest five-year swings in Equity Ratio: increased 3.68% in 2022 and later tumbled 38.99% in 2025.
  • Tandem Diabetes Care's Equity Ratio stood at 0.48 in 2021, then decreased by 12.67% to 0.42 in 2022, then dropped by 21.22% to 0.33 in 2023, then dropped by 17.41% to 0.27 in 2024, then crashed by 35.23% to 0.18 in 2025.
  • The last three reported values for Equity Ratio were 0.18 (Q4 2025), 0.15 (Q3 2025), and 0.15 (Q2 2025) per Business Quant data.